PROTEIN-BINDING INVESTIGATION BY DIFFERENCE CIRCULAR-DICHROISM - NATIVE AND ACETYLATED HUMAN SERUM ALBUMINS

被引:16
作者
BERTUCCI, C [1 ]
VIEGI, A [1 ]
ASCOLI, G [1 ]
SALVADORI, P [1 ]
机构
[1] UNIV PISA,CNR,CTR STUDIO MACROMOLEC STEREORDINATE & OTTICAMENTE,DIPARTIMENTO CHIM & CHIM IND,I-56126 PISA,ITALY
关键词
PROTEIN BINDING; CIRCULAR DICHROISM; HUMAN SERUM ALBUMIN; STEREOSELECTIVITY; DRUGS; MODIFIED ALBUMIN;
D O I
10.1002/chir.530070202
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A modified albumin was prepared by selective reaction of Lys(199) with acetyl salicylic acid. Protein binding investigation was carried out on native and modified proteins by difference circular dichroism (Delta CD). Acetylation of Lys(199) reduces significantly the effects of the interaction between drugs in the stereoselective HSA binding at specific binding areas. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 43 条
[1]   STEREOCHEMICAL FEATURES OF 1,4-BENZODIAZEPIN-2-ONES BOUND TO HUMAN SERUM-ALBUMIN - DIFFERENCE CD AND UV STUDIES [J].
BERTUCCI, C ;
DOMENICI, E ;
SALVADORI, P .
CHIRALITY, 1990, 2 (03) :167-174
[2]   LOCATION AND CHARACTERIZATION OF THE WARFARIN-BINDING SITE OF HUMAN-SERUM ALBUMIN - A COMPARATIVE-STUDY OF 2 LARGE FRAGMENTS [J].
BOS, OJM ;
REMIJN, JPM ;
FISCHER, MJE ;
WILTING, J ;
JANSSEN, LHM .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (20) :3905-3909
[3]  
BRODERSEN R, 1977, J BIOL CHEM, V252, P5067
[4]   PRESIDENTIAL MESSAGE - NEED TO RE-EVALUATE ACETYLSALICYLIC ACID (ASPIRIN) [J].
FARR, RS .
JOURNAL OF ALLERGY, 1970, 45 (06) :321-&
[5]  
FARR RS, 1966, J CLIN INVEST, V45, P1006
[6]  
FARR RS, 1961, J CLIN INVEST, V40, P1037
[7]  
FARR RS, 1971, MECHANISMS TOXICITY, P87
[8]  
FEHSKE KJ, 1978, H-S Z PHYSIOL CHEM, V359, P709
[9]   THE LOCATION OF DRUG-BINDING SITES IN HUMAN-SERUM ALBUMIN [J].
FEHSKE, KJ ;
MULLER, WE ;
WOLLERT, U .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (07) :687-692
[10]   BINDING OF 3-ALKYL-1,4-BENZODIAZEPIN-2-ONE STEREOISOMERS TO HUMAN-SERUM ALBUMIN [J].
FITOS, I ;
SIMONYI, M ;
TEGYEY, Z ;
KAJTAR, M ;
OTVOS, L .
ARCHIV DER PHARMAZIE, 1986, 319 (08) :744-749